Dynogen Pharmaceuticals' Series B Round

Dynogen Pharmaceuticals raised a round of funding on April 16, 2004.

Dynogen is a biopharmaceutical company developing drugs for gastrointestinal (GI) and genitourinary (GU) disorders, including irritable bowel syndrome (IBS) and overactive bladder (OAB). Dynogen focus…

Articles about Dynogen Pharmaceuticals' Series B Round: